Edwards Lifesciences is a global leader in the field of medical technology, specializing in innovative solutions for cardiovascular diseases. Founded in 1958 by Miles "Lowell" Edwards, the company has a long tradition of developing medical innovations.
The mission of Edwards Lifesciences is to develop innovative solutions that improve the lives of people with cardiovascular diseases through collaboration with leading clinicians and researchers. The company places great emphasis on ethical business practices and strives to be a trusted partner for patients, customers and employees.
Edwards Lifesciences is committed to sustainable and social initiatives that aim to improve the quality of life for people worldwide. The "Unifying Generations" initiative is an example of the company's commitment to connecting generations and strengthening the sense of solidarity. In addition, the company attaches great importance to ethical and responsible business practices in order to create long-term value for all stakeholders.
Edwards Lifesciences invests heavily in research and development, which is reflected in a share of around 18% of sales. This enables the company to continuously develop new and innovative products to further improve medical care.
